NASDAQ$NUWE
Nuwellis Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Nuwellis reported a revenue increase of 2% driven by consumables sales growth and gross margin improvement in Q1 2024.
Nuwellis, Inc. reported a 2% increase in revenue for the first quarter of 2024, driven by an 11% increase in consumable sales. The company's gross margin improved to 64.1% compared to 58.4% in the prior year period. Operating loss decreased due to cost-saving measures.
- Revenue increased by 2% year-over-year to $1.9 million.
- Consumables sales grew by 11% year-over-year, representing 82% of total revenue.
- Pediatric revenue increased by 40% year-over-year, with consumable sales up by 54%.
- Gross margin improved to 64.1% from 58.4% in the prior year period.
Headline financials
Revenue & EPS history
Nuwellis · Revenue · Quarterly
$1.86M
Forward guidance
Nuwellis anticipates significant expense reductions and continued positive momentum and growth in 2024.
Tailwinds
- Expects significant expense reductions through efficiency initiatives.
- New 12 cm catheter will provide increased access optionality and a new source of revenue.
- Advancing pilot phase with DaVita.
- Begin to commercialize Quelimmune™ SCD under exclusive license and distribution agreement with SeaStar Medical.
- Increased awareness of the clinical and economic benefits of the Aquadex system continues to result in healthy utilization gains demonstrating increased therapy adoption
Headwinds
- Risks associated with ability to execute on commercialization strategy.
- Possibility of being unable to raise sufficient funds for anticipated operations.
- Risks related to post-market clinical data collection activities.
- Uncertainties regarding market and physician acceptance of products.
- Potential risks from competitive product offerings.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
-5.5%
Avg return
Earnings day
-10.5%
Avg return
5 days after
-18.5%
Avg return
30 days after
28%
15 / 54 earnings
Positive
+51.9%
Q1 2024
Best reaction
-29.9%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | -5.0% | -86.3% | |
| Q4 2025 | +2.4% | -2.3% | -16.3% | |
| Q3 2025 | -3.4% | -11.9% | -18.0% | |
| Q2 2025 | +0.4% | +8.4% | -24.0% | |
| Q1 2025 | -3.1% | -5.1% | -68.7% | |
| Q4 2024 | -4.0% | -7.9% | -25.4% | |
| Q3 2024 | +6.6% | -0.6% | -28.2% | |
| Q2 2024 | -14.3% | -30.2% | -46.4% | |
| Q1 2024 | +51.9% | +47.1% | +29.4% | |
| Q4 2023 | -20.7% | -18.3% | -36.7% | |
| Q3 2023 | -10.0% | -12.9% | -14.3% | |
| Q2 2023 | -5.1% | -3.0% | -22.2% | |
| Q1 2023 | -29.9% | -37.8% | -34.6% | |
| Q4 2022 | -5.1% | -6.5% | -41.2% | |
| Q3 2022 | -19.6% | -16.7% | -50.0% | |
| Q2 2022 | -6.5% | -4.2% | +23.9% | |
| Q1 2022 | +1.0% | +2.9% | -7.4% | |
| Q4 2021 | -1.2% | -6.1% | +2.0% | |
| Q3 2021 | -17.0% | -13.2% | -33.3% | |
| Q2 2021 | +9.6% | +7.9% | +3.0% | |
| Q1 2021 | -14.6% | -8.9% | +6.6% | |
| Q4 2020 | +5.7% | -6.2% | -21.3% | |
| Q3 2020 | -7.8% | -7.0% | +14.1% | |
| Q2 2020 | -16.0% | -32.0% | -68.0% | |
| Q1 2020 | -9.6% | -14.6% | +2.4% | |
| Q4 2019 | -28.8% | -33.9% | -29.0% | |
| Q3 2019 | -15.0% | -23.0% | -16.0% | |
| Q2 2019 | -1.2% | +2.0% | +0.4% | |
| Q1 2019 | -13.3% | -13.3% | -24.9% | |
| Q4 2018 | -12.6% | -25.6% | -69.8% | |
| Q3 2018 | +2.8% | +4.7% | -21.7% | |
| Q2 2018 | -26.4% | -37.4% | -23.9% | |
| Q1 2018 | -17.1% | -18.8% | -23.3% | |
| Q4 2017 | -15.5% | -25.7% | -21.0% | |
| Q3 2017 | -12.8% | -15.6% | -47.3% | |
| Q2 2017 | -4.0% | -13.3% | -6.7% | |
| Q1 2017 | -9.5% | -1.4% | -9.5% | |
| Q4 2016 | -5.3% | -12.0% | -58.0% | |
| Q3 2016 | -5.0% | -5.0% | +190.0% | |
| Q2 2016 | -14.9% | -16.0% | -17.0% | |
| Q1 2016 | +1.5% | — | — | |
| Q4 2015 | -15.9% | — | — | |
| Q3 2015 | -1.2% | — | — | |
| Q2 2015 | +0.7% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | -0.2% | — | — | |
| Q3 2014 | -17.5% | — | — | |
| Q2 2014 | +23.9% | — | — | |
| Q1 2014 | +3.2% | — | — | |
| Q4 2013 | +2.1% | — | — | |
| Q1 2013 | +6.2% | — | — | |
| Q4 2012 | +2.6% | — | — | |
| Q2 2012 | -7.6% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro